The University of Chicago Header Logo

Connection

Robert Rosenfield to Gonadotropin-Releasing Hormone

This is a "connection" page, showing publications Robert Rosenfield has written about Gonadotropin-Releasing Hormone.
  1. Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2013 Apr; 98(4):1591-601.
    View in: PubMed
    Score: 0.435
  2. Comparison of detection of normal puberty in boys by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2012 Dec; 97(12):4596-604.
    View in: PubMed
    Score: 0.423
  3. Potential diagnostic utility of intermittent administration of short-acting gonadotropin-releasing hormone agonist in gonadotropin deficiency. Fertil Steril. 2010 Dec; 94(7):2697-702.
    View in: PubMed
    Score: 0.359
  4. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study. J Clin Endocrinol Metab. 1995 Oct; 80(10):2980-6.
    View in: PubMed
    Score: 0.130
  5. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr. 1994 Jun; 124(6):989-91.
    View in: PubMed
    Score: 0.119
  6. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone. J Pediatr. 1992 May; 120(5):709-15.
    View in: PubMed
    Score: 0.103
  7. Use of nafarelin for testing pituitary-ovarian function. J Reprod Med. 1989 Dec; 34(12 Suppl):1044-50.
    View in: PubMed
    Score: 0.087
  8. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009 Apr; 123(4):e752-62.
    View in: PubMed
    Score: 0.083
  9. Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab. 2009 May; 94(5):1579-86.
    View in: PubMed
    Score: 0.082
  10. Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index. J Clin Endocrinol Metab. 2009 Apr; 94(4):1168-75.
    View in: PubMed
    Score: 0.082
  11. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity. J Clin Endocrinol Metab. 1986 Dec; 63(6):1386-9.
    View in: PubMed
    Score: 0.071
  12. GnRH agonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulating inhibin-B and activin-A. Hum Reprod. 2004 Dec; 19(12):2748-58.
    View in: PubMed
    Score: 0.061
  13. Direct inhibitory effect of estradiol on pituitary luteinizing hormone responsiveness to luteinizing hormone releasing hormone is specific and of rapid onset. Biol Reprod. 1984 Feb; 30(1):59-66.
    View in: PubMed
    Score: 0.058
  14. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5:1285-9.
    View in: PubMed
    Score: 0.044
  15. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study. J Clin Endocrinol Metab. 1996 Sep; 81(9):3408-11.
    View in: PubMed
    Score: 0.035
  16. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
    View in: PubMed
    Score: 0.026
  17. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr. 1990 Sep; 117(3):364-70.
    View in: PubMed
    Score: 0.023
  18. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
    View in: PubMed
    Score: 0.021
  19. Estradiol inhibition of pituitary luteinizing hormone release is antagonized by serum proteins. J Steroid Biochem. 1986 Sep; 25(3):309-14.
    View in: PubMed
    Score: 0.017
  20. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab. 1985 Sep; 61(3):508-13.
    View in: PubMed
    Score: 0.016
  21. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies. J Clin Endocrinol Metab. 1989 Nov; 69(5):963-7.
    View in: PubMed
    Score: 0.005
  22. Endocrinologic characteristics of partial ovarian failure. J Clin Endocrinol Metab. 1976 Aug; 43(2):449-52.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.